Podcasts about olesen

Der 1.FC Köln verliert zu Hause gegen Hertha BSC Berlin und wir müssen reden. "Müssen" deshalb, weil es eigentlich keinen Sinn macht. Das Hamsterrad dreht sich weiter, der FC spielt wieder einmal grottenschlecht. Es fehlt ein Konzept, es fehlt an Selbstvertrauen, es fehlt ein Plan. Olesen und Thielmann hatten schon deutlich bessere Tage, auch Kainz hat nach seiner Einwechslung nur einen Akzent setzen können. Aber nicht nur Negatives bringt das Spiel mit sich: Julian Pauli ist wieder am Start. Nach seiner schweren Verletzung gab er sein Comeback gegen die Hertha. Schauen wir nach vorne: Wir gewinnen das nächste Spiel gegen Fürth. Irgendwie. Wird schon, hoffen wir! Auch in der #291 haben wir wieder tolle Hörerfragen von Euch erhalten, die wir versuchen zu beantworten. Chapter Marks: 00:00:00 Intro 00:00:52 Begrüßung 00:03:27 Rückblick Hertha 00:53:13 Vorschau Fürth 01:02:38 Hörerfragen 01:16:42 Suche: Trikot 01:18:11 Saisonspende + Verabschiedung Das Team TdH: * Daniel (@DanielGmann) * Denis (@kylennep) * Eric (@hibarian2) Viel Spaß beim Hören! Den Podcast unterstützen: www.trotzdemhier.de/spenden Intromusik: Sascha Brinkmann Folgt uns auf BlueSky oder Insta (Handle jeweils /TrotzdemHier) und rezensiert uns bei iTunes & Co. Jetzt auch wieder live auf Twitch: www.twitch.tv/trotzdemhierpodcast

Jakob og Esben har været til EU-konference og mødt italiens tidligere premierminister, Enrico Letta. De kigger på det skærpede konfliktniveau mellem USA på den ene side og Danmark og Grønland på den anden. Og til sidst diskuterer de Signal-Gate og Mar a Lago Accords for at finde ud om Trump rimer på kaos eller en snedig plan om omdannelse af hele verdensøkonomien.Ugens emner i #dkpol:Ny dansk stil over for Trump (10:48): Først skulle JD Vances kone, Usha, til hundeslædevæddeløb på et uofficielt, men alligevel meget officielt besøg. Det blev aflyst, og nu er planen, at JD Vance selv bare skal besøge de amerikanske soldater på Pituffik Space Base. Esben og Jakob diskuterer, hvad der sker med de amerikanske overtagelsesforsøg af Grønland, og hvor al den pomp og pragt, der normalt er forbundet med statsbesøg, er blevet af.Dudes på Signal (22:26): Amerikanske toppolitikere kom til at tilføje chefredaktøren fra The Atlantic i deres Signal-tråd, hvor klassificeret information blev delt. Esben og Jakob er enige om, at det er kikset og amatøragtigt – det er dudes, der snakker dude-agtigt, men hvad fortæller det os om, hvem vi egentlig har med at gøre? Esben er pessimistisk, mens Jakob er knap så sortseende.Arbejdsmarkedspensioner på EU-niveau (42:22): Esben og Jakob har været til EU-konference om det, der engang hed kapitalunionen. Ifølge Esben gav det et indblik i, hvad Bruxelles kan, og ham og Jakob deler deres takeaways fra konferencen og diskuterer, hvad det er, der forhindrer Europa i at tage fart økonomisk. Husk desuden, det er den 7. marts, at DKPOL-løbeklubben løber igen. Turen starter kl. 08:00 foran Altinget i Ny Kongensgade 10, København.Værter: Esben Schjørring, politisk redaktør på Altinget, og Jakob Nielsen, ansvarshavende chefredaktør på Altinget.Producer: Emma Klitnæs, podcastassistent.Shownotes:Esbens anbefaling: Edward Chancellor essay Interest rates, mankind's greatest inventionJakobs anbefaling: Bo Lidegaard, Jens Heinrich og Mira Maria Jo Kleist bog, Grønland – en rejse fra de tidligste tider til et moderne samfund - og Simon Mølholm Olesen anmeldelse herafNotat om Mar-A-Lago accords - A User's Guide to Restructuring the Global Trading System Hosted on Acast. See acast.com/privacy for more information.

Rasmus Neergaard-Petersen var lige ved at blive den første danske vinder nogensinde på PGA Touren. Han spillede med på en invitation i Puerto Rico, det var hans PGA Tour-debut, og han endte alene på andenpladsen. Vi taler med Rasmus her dagen derpå. Vi taler også med Jacob Skov Olesen, der bliver ved med at lægge på i sin første sæson som professionel. The Amateur-vinderen tog sit bedste resultat som professionel, da han endte på en delt syvendeplads i Sydafrika på DPWT. Vi spiller nationalsang for Søren Kjeldsen, der bankede de unge på ECCO Touren i Spanien, og så ser vi frem mod endnu en stor uge med masser af danskere i aktion, bl.a. i The Players Championship, i Indien og i Australien. Golf Showet er produceret af Qvortrup Media i samarbejde med https://www.golfexperten.dk og https://dmgreenkeeping.dk Brug koden "golf50" på http://hellofresh.dk/ og få op til 959 kr. i rabat på dine fem første måltidskasser og gratis fragt på den første.

Vi hører om dem igen og igen. De lystdrevne, sadistiske psykopater, der slår kvinder ihjel. For de fleste mennesker er ondskaben i gerningsmændenes modbydelige handlinger umulig at forstå, men professor i social- og personlighedspsykologi Henrik Høgh-Olesen har undersøgt ondskabens anatomi. Hvor kommer ondskaben fra? Har alle mennesker ondskaben i sig? Og hvor kommer den store fascination af det onde fra, når vi ser true crime eller følger intenst med i en retssag, der ikke har noget med os at gøre? Gæst: Henrik Høgh-Olesen, professor i social- og personlighedspsykologi ved Aarhus Universitet Vært: Jacob Grosen Tilrettelægger: Pernille Skytte Klip og produktion: Nicolai Dupont Foto: Anthon Unger Episoden blev bragt d. 31. majSee omnystudio.com/listener for privacy information.

Vi er på hjemmebesøg og sidder i en lille time sammen med Søren Kjeldsen og hans søn Emil, der gik caddie på tourskolen i sidste uge. Søren Kjeldsen tog med en decideret magtdemonstration et af de fem eftertragtede kort til den amerikanske seniortour, PGA Tour Champions. Han vandt tourskolen med Emil på baggen, og vi taler i dagens afsnit (37:25) med både Søren og Emil om den store præstation. Thorbjørn Olesen blev bedste dansker i Sydafrika, hvor det for anden uge i træk endte med en amerikansk sejr. Vi samler op på diverse tourskoler i USA, og så ser vi frem mod denne uges nervepirrende tourskole til Ladies European Tour, der spilles i Marokko, og hvor to danskere i denne uge spiller pre-qualifier. Golf Showet er produceret af Qvortrup Media i samarbejde med https://www.golfexperten.dk og https://shapingnewtomorrow.dk Brud koden "golf" på https://aioss.dk og spar 100 kr. på dit abonnentent de første tre måneder eller på købet af en enkelt pose.

What's the next big concept in the data world? Meet the Meta Grid—a decentralized architecture inspired by microservices and data mesh, introduced by Ole Olesen-Bagneux, O'Reilly author of The Enterprise Data Catalog. Spoiler: the Meta Grid already exists within your organization, and it's not a technology! In this episode, Ole joins us to unpack what the Meta Grid really is (and isn't) and why it's poised to transform the way we think about enterprise data.   Enhance you listening experience with C&C Chat at www.data.world/podcasts

What's the next big concept in the data world? Meet the Meta Grid—a decentralized architecture inspired by microservices and data mesh, introduced by Ole Olesen-Bagneux, O'Reilly author of The Enterprise Data Catalog. Spoiler: the Meta Grid already exists within your organization, and it's not a technology! In this episode, Ole joins us to unpack what the Meta Grid really is (and isn't) and why it's poised to transform the way we think about enterprise data.

What if the world's metadata were interconnected in a decentralized way? This is part of the vision of Ole Olesen-Bagneux's Meta Grid. We have a chat about what it is, and its implications for the data industry.

Andy's on the road so Brendan put together an ensemble episode for your Friday listening pleasure! First, he's joined by Fried Egg Golf's Joseph LaMagna to discuss the RSM Classic, the Australian PGA, and the LPGA's Tour Championship. Ahead of a potential Browns snow game on Thursday Night Football, Joseph asks if the movement of NFL teams to domed, turf stadiums is part of the homogenization of venues and ties this to the golf courses we see on the PGA Tour. Speaking of the PGA Tour, Joseph and Brendan dive into the first round of the RSM Classic, the final event of the 2024 season. With a lot of focus on the "Bubble Boys" hovering around the Top 125 line, PJ brings a new coverage conspiracy to light, leading Brendan to assure everyone that PGA Tour Live is not actively plotting against YouTubers. Joseph shares the latest projections for who will keep their card for 2025, with some players who earned free points from sponsor exemptions into the no-cut Zozo falling on the right side of things as of now. Brendan and Joseph then move down under to the Australian PGA where podcast favorite Jacob Skov Olesen was hit with a slow-play penalty in his DP World Tour debut. Olesen turned down his Masters exemption as an amateur in favor of turning pro after earning his DP World Tour card at Q-School, prompting Joseph to preview his upcoming article looking at how WAGR points are earned and the overall state of the high-level amateur game. After that, Brendan chats with Josh Carpenter of Sports Business Journal about Comcast's decision to spin-off its cable channel offerings, including Golf Channel, into a new company, "SpinCo." Josh shares what this may mean for the future of Golf Channel, the sport's media deals as a whole, and how the PGA Tour itself continues to evolve as a media outlet. Finally, Brendan and PJ talk some TGL ownership news in a Friday Swag Sports Minute before wrapping up this episode with a few Golf Advice questions.

Doug is honored to have Executive Director Paul Yates on the show to share I've Got A Name's mission to end sex trafficking in Lincoln and across Nebraska. Plus we catch-up with The Voice Finalist and Recording Artist Bryan Olesen. https://ivegotaname.org https://votaband.com

Chadd Olesen, CEO of automation technology company AVRL, joined us this week to discuss his company's journey. AVRL started in 2017 focused on natural language processing, but pivoted in 2020 to automate spot freight pricing for brokers. Chadd shared how AVRL had to rethink their approach and technology to better fit the needs of freight brokers, rather than trying to force brokers to adapt to their original product. He emphasized the importance of being consultative and collaborative with brokers, allowing their domain expertise to shape the automation rather than fully replacing the human element.The conversation also touched on the evolving API pricing landscape, the challenges of change management when implementing new technology, and Chadd's personal growth as a leader in navigating the complexities of the freight industry. Overall, the episode provides insights into building a successful freight tech company by deeply understanding the industry and empowering rather than replacing human expertise.***Episode brought to you by Rapido Solutions Group. I had the pleasure of working with Danny Frisco and Roberto Icaza at Coyote, as well as being a client of theirs more recently at MoLo. Their team does a great job supplying nearshore talent to brokers, carriers, and technology providers to handle any role necessary, be it customer or carrier support, back office, or tech services.***

Rasmus Højgaard var lige ved at gøre sin bror kunsten efter og vinde sæsonfinalen i Dubai, men Rory McIlroy fik sin revanche. Det ændrer ikke ved, at Rasmus følger med Niklas Nørgaard og Thorbjørn Olesen til USA, hvor de nu gør Nicolai Højgaard selskab på PGA Touren. Nicole Broch Estrup er tilbage på LPGA, Nelly Korda vandt for syvende gang i år, og så fik vi to nye danskere videre fra tourskolen til DP World Tour, hvor én missede med et enkelt slag. Vi har fanget Alexander Frances (1:29:00) i Australien, hvor den nye sæson allerede starter på torsdag. Vi binder en sløjfe på DP World Tour-sæsonen, vi siger farvel til Henrik Knudsen og Leif Nyholm, og så starter vi et nyt fantasy-spil med gode præmier. Golf Showet er produceret af Qvortrup Media i samarbejde med https://www.golfexperten.dk og https://shapingnewtomorrow.dk Brug koden "golf" på http://aioss.dk/ og spar 100 kr. på dit abonnement i tre måneder eller på købet af en enkelt pose. Spar op til 1.199 kr. på dine fem første måltidskasser på http://hellofresh.dk/. Brug vores kode "golfshowet".

Det er tid for sæsonfinaler og konklusioner. Nicolai Højgaard kommer til at misse titelforsvaret i sæsonfinalen i Dubai, mens Thorbjørn Olesen med en tredjeplads i Abu Dhabi spillede sig meget tæt på at forny sit PGA Tour-kort. Tre danskere står nu med mindst det ene ben i USA inden denne uges sæsonafslutning i Dubai. Vi varmer op til finalen og ser på danskernes muligheder. Tourskolen til DP World Tour er i fuld gang, og der skal uddeles Challenge Tour- og DP World Tour-kort. Der resterer to runder i talende stund, men også her kan vi drage de første konklusioner med en reportage live fra Spanien. Denne uge kommer desuden til at give os svar på danskernes skæbner på LPGA. Golf Showet er produceret af Qvortrup Media i samarbejde med https://www.golfexperten.dk og https://shapingnewtomorrow.dk Brug koden "golfshowet" på http://hellofresh.dk/ og spar op til 1.199 kroner på dine fem første måltidskasser.

Doug is honored to be broadcasting live from the I've Got A Name annual fundraiser & awareness night. Executive Director Paul Yates shares I've Got A Name's mission is to end sex trafficking in Lincoln and across Nebraska. Plus we catch-up with The Voice Finalist and Recording Artist Bryan Olesen who will be performing at tonight's event. https://ivegotaname.org

Esto es un fragmento del programa del martes 5 de noviembre con el repaso a toda la jornada en la Eurocup para los equipos españolesEn la Eurocup el Joventut viaja a Trento, el Dreamland Gran Canaria recibe a los Wolves Vilnius y el Valencia Basket jugará en casa del Aris de TesalónicaGIGANTES DAILY es un programa de Gigantes Podcast en el que tendrás cada mañana la información que necesitas de NBA, Euroliga, ACB, FIBA, femenino y más.Dale a seguir y cada mañana, de lunes a viernes, recibirás el boletín con el parte de noticias y un tema clave que va a marcar ese día en el mundo del baloncesto. Todo ello de la mano de Gigantes del Basket, el único medio profesional en España que lleva desde 1985 centrándose en exclusiva en el baloncesto. Más en Gigantes.com y nuestras redes socialesCompra el último número de la revista en papel en este enlace o en la Tienda GigantesSuscríbete a nuestro canal de YouTube

Esto es un fragmento del programa del martes 5 de noviembre con el repaso a toda la jornada en la Basketball Champions League para los equipos españolesEn la BCL el Unicaja jugará en casa del Aliaga Petkimspor turco y el UCAM Murcia en Belgrado contra el FMPGIGANTES DAILY es un programa de Gigantes Podcast en el que tendrás cada mañana la información que necesitas de NBA, Euroliga, ACB, FIBA, femenino y más.Dale a seguir y cada mañana, de lunes a viernes, recibirás el boletín con el parte de noticias y un tema clave que va a marcar ese día en el mundo del baloncesto. Todo ello de la mano de Gigantes del Basket, el único medio profesional en España que lleva desde 1985 centrándose en exclusiva en el baloncesto. Más en Gigantes.com y nuestras redes socialesCompra el último número de la revista en papel en este enlace o en la Tienda GigantesSuscríbete a nuestro canal de YouTube

Fredericia Missionhus, okt 2024

Jørgen Olesen er Årets Legende 2024 i AGF.I denne podcast fortæller hans søn, Steffen Olesen levende og nærværende om sin far og Jørgen Olesens karriere i AGF i 1950'erne og 1960'erne, hvor AGF vandt mesterskaber og pokaler flere år i træk.Vi hører også om, hvordan det var, at være fodboldspiller i gamle dage og, hvilken betydning historiens spillere har for en fodboldklub i vor tid. Og mange andre gode historier fra da far var dreng og fodbolden af brunt læder. Jørgen Olesen hyldes mandag den 21. oktober til AGF's hjemmekamp mod Brøndby IF i Ceres Park..Medvirkende: Steffen OlesenVært: Søren Højlund CarlsenMusik: Grant Green, Alive!Produceret af AGF

I endnu en uge med masser af dansk succes løb Hamish Brown med overskrifterne da han tog sæsonens anden sejr på Challenge Tour i Kina og cementerede sin oprykning til DPWT. Vi taler med Hamish om sæsonens SJETTE danske sejr på Challenge Tour. Vi har også en snak med Jacob Skov Olesen, der siden sejren ved The Amateur Championship i sommer har skullet tage stilling til sit dilemma. Skal han jagte status som pro nu eller vente til efter Masters og US Open…? Det giver han i dag sit svar på. Jeff Winther og Thorbjørn Olesen delte andenpladsen i Paris, seks danskere endte i top 20, og så får vi i denne uge svar på om vi får to eller tre danskere på Challenge Tour fra Nordic League og ECCO Tour. Golf Showet er produceret af Qvortrup Media i samarbejde med https://shapingnewtomorrow.dk og https://www.golfexperten.dk. Brug koden "golfshowet" på http://hellofresh.dk/ og spar op til 1.199 kr. på dine fem første måltidskasser.

Emilie voksede op i Pinsekirken. Hun kendte knapt nok nogen ikke-troende mennesker - eller til evolutionsteorien - før hun kom i gymnasiet.  I dag er hun 25 og tror ikke på guder, men arbejder stadig med troen og dens effekter. Blandt i podcasten "Min tro, dit traume", hvor hun taler i dybten om tingene med sin gamle veninde Liv, som stadig er kristen. 

Den nyligt afdøde Kjeld Olesen fortæller i dette afsnit af Ministertid om de udfordringer, han måtte forholde sig til som henholdsvis forsvars-, trafik- og udenrigsminister. Sammen med Simon Emil kommer han både omkring hans nænsomhed i beslutningerne omkring besættelsen af Bådsmandsstræde Kaserne, som nu er blevet til Christiania, og da han som trafikminister havde bundet sin prestige op på broen over Storebælt og nægtede at fortsætte på posten, da det blev udsat at bygge broen. Olesen fortæller også om datidens udfordringer med Sovjet, som så anderledes ud end i dag, og om da han takkede ja til drømmejobbet som udenrigsminister, som endte med at blive en hård tid efter NATO's dobbeltbeslutning.Afsnittet blev udgivet første gang i 2022.Vært: Simon Emil Ammitzbøll-BilleGæst: Kjeld Olesen Hosted on Acast. See acast.com/privacy for more information.

Canadian journalist Nora Loreto reads the latest headlines for Friday, June 7, 2024.TRNN has partnered with Loreto to syndicate and share her daily news digest with our audience. Tune in every morning to the TRNN podcast feed to hear the latest important news stories from Canada and worldwide.Find more headlines from Nora at Sandy & Nora Talk Politics podcast feed.Help us continue producing radically independent news and in-depth analysis by following us and becoming a monthly sustainer.Sign up for our newsletterLike us on FacebookFollow us on TwitterDonate to support this podcast

Indomethacin-responsive headache disorders are rare conditions whose hallmark is an absolute response to the medicine and include paroxysmal hemicrania and hemicrania continua. In this episode, Gordon Smith, MD, FAAN, speaks with Peter Goadsby, MD, PhD, FRS, author of the article “Indomethacin-Responsive Headache Disorders,” in the Continuum® April 2024 Headache issue. Dr. Smith is a Continuum® Audio interviewer and professor and chair of neurology at Kenneth and Dianne Wright Distinguished Chair in Clinical and Translational Research at Virginia Commonwealth University in Richmond, Virginia. Dr. Goadsby is a professor of neurology at King's College London in London, United Kingdom and professor emeritus of neurology at the University of California, Los Angeles in Los Angeles, California. Additional Resources Read the article: Indomethacin-Responsive Headache Disorders Subscribe to Continuum: continpub.com/Spring2024 Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @gordonsmithMD Guest: @petergoadsby Transcript Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum, the premier topic-based neurology clinical review and CME journal from the American Academy of Neurology. Thank you for joining us on Continuum Audio, a companion podcast to the journal. Continuum Audio features conversations with the guest editors and authors of Continuum, who are the leading experts in their fields. Subscribers to the Continuum journal can read the full article or listen to verbatim recordings of the article by visiting the link in the Show Notes. Subscribers also have access to exclusive audio content not featured on the podcast. As an ad-free journal entirely supported by subscriptions, if you're not already a subscriber, we encourage you to become one. For more information on subscribing, please visit the link in the Show Notes. AAN members: Stay tuned after the episode to hear how you can get CME for listening. Dr Smith: This is Dr Gordon Smith. Today, I've got the great pleasure of interviewing Dr Peter Goadsby on indomethacin-responsive headache disorders, which is part of the April 2024 Continuum issue on headache. Dr. Goadsby is a Professor of Neurology at King's College London, in London, United Kingdom and a Professor Emeritus of Neurology at the University of California, Los Angeles, which is located in Los Angeles, California. Dr Goadsby, welcome to the podcast. Well Peter, I'm super excited to have the opportunity to talk to you. And I think, before we begin, we probably ought to expand on your introduction. I think there may be three or four neurologists who don't know who you are, and I think they should know who you are because you've got a really amazing story. These are exciting times in headache, right? And a lot of that's because of your work and you've been widely acknowledged for that; you received the appropriately named “Brain Prize,” which (if I'm correct) is the largest neuroscience award in the world; got to meet Danish royalty; you're - more recently, the ABF Scientific Breakthrough Award, which is super excited. So, particularly interested in hearing about your Continuum article. But before we get there, I think it would be really great to hear your story. How did you get into this in the beginning, and what's inspired you along the way to the many achievements you've had? Dr Goadsby: Why, it's a very kind introduction. People have been nice to me. It has to be said, Danish royalty were very nice, I have to say, and the very jolly chap, the Prince of Denmark. I got into neurology - I guess it's all about mentoring for me. I got into neurology because I got into medical school pretty much by accident. I really wasn't that interested and heard a lecture by James Lance, who was Professor of Neurology, University of New South Wales, at the time. He was talking about a nondominant parietal lobe. I'd seen the case as a medical student; it sort of just seemed weird to me and I wasn't that interested. But he set out this way of thinking about things to try and understand why a clinical presentation is what it is - what he described as a physiological approach to clinical neurology. He described a number of things, but he described that in this lecture and then gave a reference to some work that Mountcastle did on nondominant parietal recordings from awake behaving monkeys in the Journal of Neurophysiology. And I thought to myself, “Wow, this is really interesting - you could really get to the bottom of something,” and had that sort of “puzzle-y” thing going on. And I thought Lance was just wonderful, so I became interested in that. And then eventually I asked him about research - actually, I asked him about research after a lecture he gave on migraine, and the explanation of the time was some circulating substance - probably just as silly now. I went up to him afterwards and said to him, I thought the explanation he was giving was wrong. Like, here was a global person - he described Lance-Adams syndrome; this was someone who trained at Mass General, trained at Queen Square; was the first professor of neurology in Australia. I was just – like, it was a stupid thing to do. But I couldn't resist myself - I told him I thought it was wrong. And he's very polite, and he said, “Well, perhaps you could come and help us by doing some research.” And I thought, “Okay, that's a very nice response.” Interestingly, his daughter described him as unfailingly polite at his funeral. Of the many things you'd say about him, he was a kind person. Whether it's science or just the way you practice - that word (kind) - you can know as much about a subject as you like, but if you're not kind to patients, you're probably in the wrong game. He taught me to be curious about a problem and got me interested in headache, and to be kind in clinical practice - just kind – and I think they were very important lessons. So, I got into it because of excellent mentoring, and I'd like to think I've helped some others along the way. Dr Smith: Well, you certainly have helped a lot of people, Peter, and what a great story. I'm reflecting - I think the first vignette in The Man Who Mistook His Wife for a Hat was a right parietal syndrome - wasn't it? You've read that book? Dr Goadsby: Yes, I have. And I've met Sacks. When Sacks came to Australia, he wanted to see Lance, and Lance said, “Fine, but you have to meet me between the morning round and the afternoon clinical meeting.” And he got him to come and have lunch with him in the hospital cafeteria at the Prince Henry Hospital and invited me to this lunch. And I sat there and watched them chat. But it was a measure of Lance and how people were interested in him that Oliver Sacks had to get in a taxi and come out to a hospital cafeteria to have lunch if you wanted to have a chat. Because it was - it was a privilege to train with the person. You know, I've done okay, but I only do okay if you've got – you know, you can work with patients, you've got great collaborators, and you've got someone you can get advice from (a great mentor). Dr Smith: Yeah, that's actually really great words of wisdom for the residents and fellows and junior faculty listening to this. Maybe we should actually talk about your article, which was really great. Your article was on indomethacin-responsive headaches - and we can maybe talk about some specific questions - but what's the main take-home point? If our listeners needed to take or were to take home one point from your article, what would it be, other than it's indomethacin-responsive (that's in the title)? Dr Goadsby: Yeah, it's what it says on the jar. Well, I think the one thing to take home is that there are forms of headache that seem relatively pedestrian, like one-sided headache that feels like it ought to be migraine that's strictly one-sided, and a small percentage of them respond almost like switching a light off to indomethacin. So, I think you have to have a high index of suspicion. And I'm sure I give indomethacin to ten, twenty times as many people - or thirty - who end up (or even more, probably) who end up having a response. But we do it for a short period of time. For those who get the response - I can tell you, when they come back, they're crying, their partners crying, or the other day I saw one, their child's crying, because all of a sudden, you've basically fixed the problem up. So, the message would be, if you've heard about something and it feels a bit “maybe, could be” - you've heard this indomethacin thing - just do it for a couple of weeks. The worst thing that can happen is nothing (nothing happens). For a couple of weeks, they're not going to have a problem with the tummy (and I'm not advocating taking people with a active gastric ulcer, trying to bump them off). But you cover them properly, you give them a short trial, and occasionally in your practice, you will be so rewarded by that - you will dance home. Dr Smith: Well, this is going to be my next question. There are very specific criteria, right, for defining cluster, SUNCT, SUNA (and there was a really great Continuum Audio conversation I had with Mark Burish I'll refer our listeners to about cluster, SUNCT, and SUNA), but the indomethacin-responsive headaches - and even migraine - that sounds to me, as someone who's not a headache person, like, that could be challenging to sort out. If you see someone who has consistent, unilateral headache, do you just do an indomethacin trial, or do you select based on other criteria from the classification system? Dr Goadsby: I'd like to think I was aware of the criteria, and I am. But the longer I practice, the more I'm inclined simply to give the indomethacin and get the question off the table because I don't think there's a sine qua non; there's nothing that will - apart from the indomethacin effect - there's nothing that will convince me 100% to be able to not do it. I've seen enough people who haven't clearly read the classification in detail (patients, I mean) and took indomethacin, and got a response where you wouldn't have predicted it, and they're very happy and the story ends well. So, I would advise people not to worry too much about whether it ought to or not respond, but find out if it does. Dr Smith: So, the obvious next question is, how does this work? It's pretty unusual in medicine, certainly in neurology, to have something that's so dramatically effective. What's the mechanism? Dr Goadsby: Well, that's the easiest question - we don't understand it. It is particular to indomethacin - it's weird. Some patients will say, “We'll give you a little bit of a hint by telling you (maybe) that ibuprofen was useful,” but most don't give you that much of a hint (some will even say aspirin is useful). But we haven't really gotten to the bottom of it. What are the current thoughts? It must be something that's not simply cyclo-oxygenase because other cyclo-oxygenase inhibitors don't do that – so, that's helpful. The other broad things people think about are whether there's a nitrergic aspect to it. We've got some basic science work that can show that nitrergically induced changes in experimental animal model of these trigeminal autonomic cephalalgias can be modified by indomethacin in one part of the model, where naproxen (for example) can't. So, we think there may be a nitrergic component to it. The other thing is the structure of the molecule makes you think about melatonin, if you put the two up – it's a work in progress. Of the things I would like to do in my life, I'd really like to get to the bottom of it, I have to tell you, because if we could work out what it is that's great about indomethacin and then get rid of the GI thing . . . Then, if you talk about cure - because when people get a response to this (you know, the oldest reported case with a response took it for thirty-seven years; they died of something else) - and continue to respond. It's one of the sort of upsides and downsides when you diagnose it - you can tell a person that they're going to continue to respond (take a breath) until they die basically, because unfortunately, the problem doesn't tend to settle down - at least the treatment stays consistent. If we could get rid of the tummy problem, that would be real progress. Dr Smith: So, what do you do with the patient who has the tummy problem? Is there another approach? Dr Goadsby: Well, there's a range of things you try and do; you use PPIs (proton pump inhibitors) and H2 blockers pretty liberally; you try to get the lowest dose, and that's usually best done by the patient. I give them the ordinary-release indomethacin; it's an impression that I have, over the years, that the slow-release indomethacin is not as efficient (just as a recommendation). I let patients - they take it three times a day, or twice - I let them work out what the littlest amount is that they need, having given them a regime to iron it out, because they can work it out for themselves. It's a partnership. It'll be very individual. If someone wants to take two in the morning and one at night and feels happy, have at it. If they want to take one three times a day, if they want to take one at lunchtime - whatever they - let them work out the minimal amount. And the other thing that we found useful - small percentage (maybe one in five) will find the coxibs useful (like celecoxib), but that's not universal at all; it generally takes the edge off. A palpable percentage will find adding melatonin in can be indomethacin sparing. Then the other (probably most important) thing is that the noninvasive vagal nerve stimulator can be very useful in reducing indomethacin dosing or even getting patients entirely off indomethacin dosing. How that works, of course, is as mysterious in the sense of these problems as is indomethacin. But that's something really worth thinking about - can be very, very useful in getting the doses down. Dr Smith: You've been doing this for a while, right? And you've seen a lot of – Dr Goadsby: Let's not emphasize that “for a while” side, right, okay? Dr Smith: For a while – just a little while, Peter. Dr Goadsby: A little while. Dr Smith: I'm just thinking - and I'm a neuromuscular guy, so give me a little latitude - but when I was a resident, our concept of headache was pretty simple; it was migraine, classic or common, and we knew a little bit about cluster. And no one talked about SUNCT or SUNA or all these other things, and wow, what an amazing several decades it's been. What's the future look like? And - maybe think big – so, is a cure for migraine in the foreseeable future? What's coming next? Dr Goadsby: If you think really big (and I'll think really big), if “cure” means that we could control it sufficiently that you wouldn't notice it, I think that's very much - it's almost here, for some. Now, I think of it like cholesterol - someone's got high cholesterol; they take a statin, and if they don't get any problems, the cholesterol normalizes. I'm simplifying things (I'm not a cardiologist), but you take your cholesterol tablet - you take it once a day; everything's fine and dandy. You never get “cured,” as such, but the effect is an effective cure from manifestations of the problem - and I am simplifying things a little bit. If I look at it like that, then I think we're getting to a place where some patients, we can treat them so well, and the problem is so suppressed, and they have so few problems with side effects (and some have none), that we're really getting there. We saw a study of the promontory phase of migraine using a gepant (ubrogepant), and we saw the ability (if you recognize the attack early enough) to treat and never have pain. Never have pain. Well, that's pretty close. It might sound crazy to think about it as a cure because someone will say, “Well, they've still got their genes,” and so on. Fine. But migraine is about disability, and if you can stop the disability and give a person full function in their life, well, you're pretty much there. And we're getting there, as we understand the disease. Dr Smith: Really amazing. I have another question that I've actually been really dying to ask you. I'm a peripheral nerve guy, and you may not be aware of this, but those of us who are interested in therapeutic development in peripheral neuropathy, or advocacy, or recognition of neuropathy as a substantive, meaningful entity, are inspired by the work of you and your colleagues in headache. Examples might be advocacy for federal funding or having CDMRP funding - things like this. But an area where - I'm just curious - we spent a lot of effort (and it seems like it's been really transformational for you guys) is having taxonomy, which isn't a particularly sexy topic. But maybe you can talk about the power of having a taxonomic classification and getting towards a cure. Because looking through this Continuum issue - it's really remarkable – it's just all sorts of things that I never would have thought of twenty years ago, and each of them is treated a bit differently. Dr Goadsby: Yes. As with all things in medicine, if you don't get the diagnosis, you can't get to the base - you've got to be able to get a diagnosis. And our taxonomy, the International Classification of Headache Disorders, has gone through three editions. We're working on the fourth. I have the privilege of being the chairman for the fourth edition (the first three were chaired by Jes Olesen). I do think it's one of the absolute achievements of our field (and Olesen needs to be really feted for doing this) that we have a definition system - it's operational; it's reasonably straightforward; it's been translated into, like, forty languages; that every government on the planet that I know of - and I'm talking about (I think I'd better mention no governments) but every big government you can think of, without exception, has adopted (‘cause I'll just get in trouble with the ones I've mentioned) have all adopted this classification; all the health technology assessments (the FDA, for example; the European Medicine, for another example), the Chinese government (People's Republic), Taiwan. Just, all over the world, people use one thing. So, if we do a randomized control trial - there's one recently came out; it doesn't really matter which gepant it is - but you look at the results in North America, and then you look at the results that were done by the Chinese and the South Koreans in a study, and the placebo rates and the active rates are more or less identical. Because what we've been able to do is homogenize who gets into clinical trials and understand what's happening. So, if I get up and talk about whatever we're going to talk about now, like, in rural India, people will know what we're talking about; all the neurologists will be on the same page and so we can make progress. And when we make progress, it's global progress because we sing from the same hymn sheets. I think the taxonomy has been really important for this. And, of course, if you get the diagnosis right, then you can start to begin to get the treatments right and you can bring all the knowledge from randomized controlled trials. There's no point having a whole lot of data if you can't apply it, and what's great about our taxonomy is we can apply it everywhere in the world. Dr Smith: Wow, what a cool answer. So, I have a follow up question for you, Peter, which has to do with reproducibility. This is a huge issue, right? In reproducibility and clinical trial evidence and in many fields, this has been a big issue - in psychiatry and other areas of neurology, where trials are nonreproducible. To what extent do you think this problem in other fields is a taxonomic problem, or a internal validity problem, in terms of the populations being recruited? I'm really impressed to hear that you don't have that problem in headache. Dr Goadsby: I do think one of the advantages that the International Classification of Headache Disorders has given us (International Headache Society being the proponent of that) is that there's clinical homogeneity, relatively speaking, in our clinical trial populations. This comes back to the clinic; good clinical trials are as much about the clinicians who are involved and the care they take in recruiting patients, and so on. Which is not to say that psychiatrists are not careful - not at all. But I do think that if you want to just test a question, everyone in the laboratory will tell you that you need to have - say you're doing work with rodents, for example; you want about the same weight, you want the same strain, they're eating about the same, they're up and down at night - everything is about the same. If you want to do good clinical trial work, you have to tidy up as much as you can so the only thing that's really impacting upon the question is the medicine, or the placebo, or whatever that you're testing. So, I think you're right. I think sometimes the pain people struggle with this because, as you say, a painful neuropathy can come from a lot of places. Well, if you just take all of those etiologies, you throw them into one study, and you test it against something, it doesn't surprise me that that's not so useful, compared to taking an individual thing that's really well defined - where you've understood the clinical side, you've understood the pathophysiology as much as you could - and just test that, one at a time. I think that's been a good lesson for us. And that's why there's nothing that's ever failed in a migraine clinical trial (a properly designed one) that ever was useful, and nothing that was ever successful that didn't continue to be successful. Now, some things were successful, and they produced, like, liver enzyme problems - so, that's “no win-no foul” situation. But the homogeneity's been quite important, I think. And it comes back to good clinical practice. Dr Smith: Well, thank you for the roadmap - that's really, really interesting. I'd like to finish up with another shift in gears, and to talk about workforce. Obviously, we have a national shortage of neurologists in the United States. We're never going to be able to train enough headache neurologists to take care of all headache patients, and we need to think about systems of care, which I guess we could talk about. But my question for you is, what would you say - a lot of residents listen to Continuum Audio, and hopefully, more medical students in the future and now - what do you say to them about a career in headache? Listening to this, I kind of feel like I want to go do a headache fellowship - it's pretty exciting. What's your pitch to them? Dr Goadsby: I'll tell you one small thing first before I say that; I did do twelve months in clinical neurophysiology, doing nerve conduction, muscle biopsies, evoked potentials. I actually did over ninety muscle biopsies (needle muscle biopsies) when I was training, so I understand your feeling. But I just got the feeling many years earlier than you've had it. What do I say to residents? Well, headache is an area where you can make a diagnosis, you can manage the patient, and you can make them better. I'd say to the resident, “Ask - just look in the mirror and ask yourself, why did you get into medicine?” You got into medicine to help people, and headache is an area where you can really help them. Plus, there's tens of millions of people with the problem, so you will always be in demand. And one of the great things about headache (I think it's probably true of neuromuscular) is it's also a very good lifestyle choice because our problems are generally with primary headache disorders - are not emergent (people don't tend to ring you up at night), and it's not really an on-call issue. You can have a proper balanced existence (work-life balance), and you can do it in a way that's really enjoyable. And then there's an extra bonus: there's all the wonderful neuroscience and neuropharmacology that's going on in headache. I just think if a resident looks in the mirror and says, “Why am I doing this?” most of them are going to look back at themselves and say, “Because I want to do good.” And they also want to do good in a way that they can have a proper life themselves. And if they're the two answers you got back when you look in the mirror (“I want to do good” and “I want to have some life myself”) - headache - that's the place to go, because there's plenty of room and you can do both. Dr Smith: Well Peter, that's great - sign me up. And I think people know where to find you to call for a recommendation. What a great conversation and a really great article. And again, I'll refer our listeners to Mark Burish's article on cluster, which is a really great companion to your article ‘cause it gives you the full spectrum of trigeminal autonomic cephalgias (which is pretty cool), and the rest of the issue is equally amazing. Peter, you don't disappoint. The next time you see the Danish Crown Prince, say “Hi” from me (I love Denmark - it's a lovely place to be). And thanks again for doing this. Dr Goadsby: Well, thank you, and thanks for the Academy for organizing. And the other thing about residents - if you want to stay in touch with neurology, stay in touch with the Academy; they're a pretty good bunch. Dr Smith: Couldn't agree more, couldn't agree more. Again, today we've been interviewing Dr. Peter Goadsby. His article on indomethacin-responsive headache disorders appears in the most recent issue of Continuum, on headache. Be sure to check out our Continuum Audio podcasts from this and other issues. And listeners, thank you very much for joining us today.   Dr. Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practice. Right now, during our Spring Special, all subscriptions are 15% off. Go to Continpub.com/Spring2024, or use the link in the episode notes to learn more and take advantage of this great discount. This offer ends June 30, 2024. AAN members: go to the link in the episode notes and complete the evaluation to get CME. Thank you for listening to Continuum Audio.

Doug broadcasts live from the Lied Center in Lincoln, NE for the Bryan Olesen Watch Party on NBC's The Voice. Doug is joined by B107.3's Brooke Summers and John Lefler from the band AM/FM. Vote for Bryan tonight at https://voice.vote.nbc.com/

Doug brings on Andi CurryGrubb the Executive Director of Planned Parenthood Nebraska to dig into their petition to make abortion legal up to 23 weeks. Doug asks the difficult questions. Plus we hear Bryan Olesen's song that propelled him into the finals of NBC's The Voice and talked to his band partner John Wooten

Doug brings on Andi CurryGrubb the Executive Director of Planned Parenthood Nebraska to dig into their petition to make abortion legal up to 23 weeks. Doug asks the difficult questions. Plus we hear Bryan Olesen's song that propelled him into the finals of NBC's The Voice and talked to his band partner John Wooten

Doug gets an update from Bryan Olesen from LZ as he gets ready to perform in the semi-finals of NBC's The Voice. Doug also sees if the opposition to LB1402 can turn him from a Dodge & Weaver to a Supporter, as he meets with Jenni Benson & Tim Royers who represent Support Our Schools and the NSEA. They are 2/3rds of the sponsors of the petition to repeal section 1 of LB 1402, which would take out the $10 Million School Choice Scholarship Legislation that passed and was signed into law by Governor Pillen.

Chadd Olesen is back for another insightful conversation about the latest on the freight market! Today, we'll delve deeper into automation, partnerships, efficient processes, and cost management.   About Chadd Olesen Chadd is the CEO and co-founder of AVRL. For nearly a decade, Chadd has been an entrepreneur, marketer, and technology leader. In 2017, Chadd and his team launched AVRL to connect disparate systems for Fortune 500 companies. By early 2018, AVRL was working with most of the Fortune 10 & had secured two rounds of funding from extremely notable firms in Silicon Valley (SAP, Social+Capital, Fontinalis Partners & Morpheus VP). Today, leading 3PLs, Asset-Based Carriers & Enterprise Shippers leverage AVRL's technology to automate & execute disparate systems (TMS / WMS / Shipper Portals / ETC). AVRL is currently #626 on the INC 5000 & one of the fastest-growing companies in Austin, TX.  Connect with Chadd on LinkedIn: https://www.linkedin.com/in/chadd-olesen/  

Today we explore the intersection of knowledge and action with the insightful Dr. Margie Olsen. Take a listen to host Natalie Benamou and Dr. Olsen as she shares secrets of turning knowledge into meaningful deeds. Dr. Olsen, a renowned expert in applied psychology and behavioral science, will be our guide as we navigate the gap between knowing what to do and actually doing it.Get ready to discover practical strategies, actionable insights, and inspiring stories that will empower you to bridge the divide between knowledge and action.3 Key Takeaways:1. Understand the Knowing-Doing Gap: Dr. Olsen explains details behind why we often struggle to translate knowledge into action. From cognitive biases to environmental influences, uncover the barriers that hinder our ability to apply what we know.2. Strategies for Implementation: Explore evidence-based techniques and behavioral strategies that facilitate effective action. Learn how to overcome procrastination, cultivate habits, and design environments that promote consistent follow-through.3.Harnessing Motivation and Willpower: Discover the secrets to sustaining motivation and bolstering willpower. Dr. Olsen shares insights on tapping into intrinsic drivers, setting compelling goals, and fostering resilience in the face of challenges.Favorite Quotes:1. "I've seen countless individuals who possess vast knowledge but struggle to translate it into tangible action. Understanding this gap is the first step towards bridging it." - Dr. Margie Olsen2. "Action doesn't always require monumental efforts; sometimes, it's the small, consistent steps that lead to significant change." - Dr. Margie Olsen3. "By aligning our actions with our values and aspirations, we can ignite a powerful sense of purpose that propels us forward." - Dr. Margie Olsen"Understanding is the first step towards transformation is what we do with that understanding that truly defines us." - Dr. Margie Olsen"In the journey from knowing to doing, it's not just about taking action but also about being mindful and intentional in our choices." - Dr. Margie Olsen"True progress is not just about what we accomplish externally, but also about the growth and evolution that happens within ourselves along the way." - Dr. Margie OlsenThank you Dr. Olesen for being on the show today and a special thank you to Anastasia Lipske, Founder of Access Speakers, who connected us. Both Dr. Margie Olsen and Anastasia are members of HerCsuite® and we come full circle on our ecosystem with the original introduction from Bobbie Carlton, Founder of Innovation Women.Keep shining your light bright. The world needs you.About Dr. Margie Olsen:Website URL: www.oleson-consulting.comLinkedIn:http://linkedin.com/in/margieolesonhttps://www.facebook.com/margie.oleson/https://www.oleson-consulting.com/top-team-accelerator/HerCsuite®HerCsuite® on LinkedInNatalie Benamou on LinkedInSchedule a CallAlliance PartnersAnastasia LipskeAccess SpeakersInnovation WomenBobbie Carlton

Doug receives a special message from Bryan Olesen who is performing “live” tonight on NBC'S The Voice. He also gives us some breaking news. Then Doug is joined by Rebekah Allick (Husker Volleyball) and Paul Yates (Exec.Dir. of I've Got A Name) to share how we can help them combate and beat Sex Trafficking in Nebraska. Plus they share how we can support them by giving to them during Give To Lincoln throughout the month of May. Go to www.givetolincoln.com/nonprofits/ive-got-a-name to give!

Alex Olesen from Babylon Microfarms joins the episode to discuss sustainability in the tech space and the future of agriculture. Listen now to learn more about this exciting Richmond company and what's ahead for the RVA tech scene.

Luke Bryan falls on stage, Kate Middleton is still no where to be found, and a local guy is CRUSHING on The Voice! Thanks to our podcast partner Centris Federal Credit Union! You can rep our show! Buy some Pat and JT Podcast swag HERE! Subscribe, rate, and review our podcast wherever you get your podcasts so you don't miss an episode! Also follow up on Facebook, Twitter, and Instagram This is another Hurrdat Media Production. Hurrdat Media is a podcast network and digital media production company based in Omaha, NE. Find more podcasts on the Hurrdat Media Network by going to HurrdatMedia.com or the Hurrdat Media YouTube channel! Learn more about your ad choices. Visit megaphone.fm/adchoices

Doug is joined by Local Artist and “The Voice” Contestant Bryan Olesen & Acton Academy Co-founder Zach Harsin. Bryan shares about his Voice experience and Watch Party. Zach shares about Lincoln Children's Business Fair sponsored by Acton.

This week, Nathanael is joined by Bryan Olesen to talk about being coached by John Legend, being labeled as Mr. Potato Head and Bryan answers some burning questions. Host: Nathanael Reyes Guest: Bryan Olesen https://linktr.ee/imnathanaelreyes Follow @imnathanaelreyes Shop Mad Rabbit Products (CODE: REYESREFLECTION For 20% OFF) https://www.madrabbit.com/collections/all-products Shop Jocko Fuel (CODE: REYESREFLECTION For 10% OFF) https://store.jockofuel.com Shop Arave Cards https://www.ebay.com/str/aravecards https://m.facebook.com/people/Arave-Cards/100090481594642/

Please Rate and Review us on your podcast app of choice!Get involved with Data Mesh Understanding's free community roundtables and introductions: https://landing.datameshunderstanding.com/If you want to be a guest or give feedback (suggestions for topics, comments, etc.), please see hereEpisode list and links to all available episode transcripts here.Provided as a free resource by Data Mesh Understanding. Get in touch with Scott on LinkedIn.Transcript for this episode (link) provided by Starburst. You can download their Data Products for Dummies e-book (info-gated) here and their Data Mesh for Dummies e-book (info gated) here.Learn more about Data Mesh Understanding: https://datameshunderstanding.com/aboutData Mesh Radio is hosted by Scott Hirleman. If you want to connect with Scott, reach out to him on LinkedIn: https://www.linkedin.com/in/scotthirleman/If you want to learn more and/or join the Data Mesh Learning Community, see here: https://datameshlearning.com/community/If you want to be a guest or give feedback (suggestions for topics, comments, etc.), please see hereAll music used this episode was found on PixaBay and was created by (including slight edits by Scott Hirleman): Lesfm, MondayHopes, SergeQuadrado, ItsWatR, Lexin_Music, and/or nevesf

With Edwards unavailable Craig goes alone for the very first time so apologies if it's a poor quality episode. It was an interesting week with Matthieu Pavon becoming the 1st Frenchman in 117 years to win on PGA Tour with a fantastic victory at Farmers Insurance Open at Torrey Pines winning with a ballsy 3rd shot to the Par 5 18th to defeat Nicolai Højgaard! At Ras Al Khaimah it was a super Thorbjorn Olesen performance to win by 6 shots at -27 to Rasmus Hojgaard at Al Hamra GC. That was Olesen's 8th victory on DP World Tour & 3rd since 2022 a class player that can blow people away when the putter is firing! For me the event of the year so far was LPGA Drive On Champs in Bradenton, Florida on the LPGA Tour an event that saw the re-emergence of Nelly Korda who won for a 9th time on LPGA Tour in absolutely dramatic fashion defeating Lydia Ko in a playoff while Ko was looking for LPGA Immortality! Nelly would have a 4 shot lead going into Sunday would only be 1 ahead of Megan Khang after the front 9 then a poor drive at 14 would lead to a bogey at 14, double bogey at 15 followed directly by bogeys from all 3 of Khang, Ko and Ayaka Furue would put all 3 women joint lead at -9 before Ko thinned her 2nd shot to the Par 5 17th to 3ft for a tap in eagle while Korda would further bogey to give Lydia a 3 shot lead going into her 72nd hole. The drama doesn't end there Nelly at 17 from the back of the green would make a clutch eagle to go back to within 1 of Ko with Ko parring the 18th to finish -11 Korda would need to birdie 18 to get in a playoff which she produced a worldie shot into the 72nd to within a foot to bring it to a playoff where she would win on the 2nd Playoff hole in dramatic fashion in her hometown of Bradenton! This week we have AT&T Pebble Beach Pro-Am on the PGA Tour which Justin Rose won last year. This year at Pebble it is an 80 man field with no cut & a PGA Signature Event attracting the very best this week with only Pebble Beach & Spyglass Hill in play instead of the 3 course rotation of normal & the Am's are only playing Thursday & Friday leading to a good finish hopefully! It's another inaugural event on DP World Tour with Bahrain Champs taking place this week at the Colin Montgomerie designed Royal Golf Club that has hosted a few MENA Tour events from 2018-20 as well as a Champions event in the European Tour back in 2011 which was won by Paul Casey at -20. With wind forecast in Bahrain it should be a good event with hopefully the winner picked in it! Felt it was hard to go solo so appreciate it if you try to listen in! Listen & Download on Podbean, Apple Podcasts & Spotify!

IRM UK Conference, March 11-14: https://irmuk.co.uk/dgmdm-2024-2-2/ use code DM10 for a 10% off discount!Please Rate and Review us on your podcast app of choice!Get involved with Data Mesh Understanding's free community roundtables and introductions: https://landing.datameshunderstanding.com/If you want to be a guest or give feedback (suggestions for topics, comments, etc.), please see hereEpisode list and links to all available episode transcripts here.Provided as a free resource by Data Mesh Understanding. Get in touch with Scott on LinkedIn.Transcript for this episode (link) provided by Starburst. You can download their Data Products for Dummies e-book (info-gated) here and their Data Mesh for Dummies e-book (info gated) here.Ole's LinkedIn: https://www.linkedin.com/in/ole-olesen-bagneux-2b73449a/Piethein's LinkedIn: https://www.linkedin.com/in/pietheinstrengholt/Samia's LinkedIn: https://www.linkedin.com/in/samia-rahman-b7b65216/Liz's LinkedIn: https://www.linkedin.com/in/lizhendersondata/Ole's book The Enterprise Data Catalog: https://www.oreilly.com/library/view/the-enterprise-data/9781492098706/Piethein's book Data Management at Scale (2nd Edition): https://www.oreilly.com/library/view/data-management-at/9781098138851/Liz's blog: https://lizhendersondata.wordpress.com/In this episode, guest host Ole Olesen-Bagneux, Chief Evangelist at Zeenea (guest of episode #82) facilitated a discussion with Piethein Strengholt, CDO at Microsoft Netherlands (guest of episode #20), Liz Henderson AKA The Data Queen, a board advisor, non-executive director, and mentor in digital and data at Capgemini (guest of episode #106), and Samia Rahman, Director of Enterprise Data Strategy, Architecture, and Governance at SeaGen/Pfizer (guest of episode #67). As per usual, all guests were only reflecting their own views.The topic for this panel was modernizing master data management (MDM) and applying that to...

Lorie Dorrian returns to the podcast to discuss this sometimes tragic and sometimes hilarious episode! "The telephone comes to Walnut Grove, and Mrs. Olesen is hired as the switchboard operator. She takes advantage of her responsibilities to engage in her favorite pastime: gathering gossip. It will have a very damaging effect on the Garveys' marriage when she learns about Alice's hidden past." Crossed Connections originally Aired on December 10, 1979 The opening song "Albert" is written and performed by the amazing Norwegian band, Project Brundlefly and is used with permission. Check them out at: https://www.facebook.com/ProjectBrundlefly Become a Patron!

***This is another "Lost Episode" I hope it's the last! *** Marissa Baker returns to the show to discuss this sometimes hilarious and sometimes tear-jerking episode. "The telephone comes to Walnut Grove, and Mrs. Olesen is hired as the switchboard operator. She takes advantage of her responsibilities to engage in her favorite pastime: gathering gossip. It will have a very damaging effect on the Garveys' marriage when she learns about Alice's hidden past." Crossed Connections originally Aired on December 10, 1979 The opening song "Albert" is written and performed by the amazing Norwegian band, Project Brundlefly and is used with permission. Check them out at: https://www.facebook.com/ProjectBrundlefly Become a Patron!

Use code VFP100 for $100 off on the Rejuvenate Indoor Garden and 3 pod packs for freeJoin us on an exciting journey as we explore the groundbreaking world of indoor farming with Babylon Micro-Farms and their visionary CEO, Alexander Olesen. In this episode, Alexander shares his invaluable insights on sustainability, scaling, and customer satisfaction, while taking us through his remarkable entrepreneurial journey. Discover the incredible benefits of indoor farming, from its potential for local service operators and government involvement to its niche applications for self-sufficiency and unforgettable experiences. Prepare to be amazed by Babylon Micro-Farms' turnkey hydroponic farming modules and their game-changing products that are redefining the industry. With a strong focus on eliminating single- use plastic, delivering fresh and healthy crops, and fostering happy customers, this podcast uncovers the transformative impact of urban agriculture on the food service industry. Don't miss out on this opportunity to learn about the cutting-edge technology, sustainability efforts, and exciting future plans that make Babylon MicroFarms a true pioneer in the field.Thanks to Our SponsorsCultivatd – https://cultivatd.com/Indoor AgCon '22 - https://indoor.ag/Use promo code 'VFP' to receive 20% your registrationKey TakeawaysDiscover how Babylon MicroFarms is revolutionizing indoor farming with their turnkey hydroponic farming modules, attracting attention and sparking conversations about the benefits of urban agriculture.Learn about the game-changing product, the Gallery, which makes it easier than ever to grow your own fresh food and offers features for food safety traceability and scaling.Uncover Babylon MicroFarms' commitment to sustainability, with a 55% reduction in plastic, recyclable components, and zero pesticides, aiming to set the standard for eliminating single-use plastic.Dive into the Alexanders's journey, from wearing different hats to managing fundraising efforts, and how their decision to manufacture their own products amplifies their ability to drive down costs and complexity.Explore the company's relentless focus on happy customers and healthy crops, backed by six years of research and development for scalable success.Learn about the potential for local service operators and government involvement in the indoor farming sector, drawing parallels to the subsidization of renewable energy.Discover the exciting niche applications of indoor farming, from self-sufficiency for specific ingredients to creating special moments for seniors in senior living communities and even installing units on cruise ships.Stay tuned to witness how Babylon Micro Farms' cutting-edge technology and innovative approach will transform the food service industry and urban agriculture.Tweetable Quotes“Our goal is to empower businesses and communities to grow their own fresh food using remotely managed vertical farms. So we build turnkey modules that are sort of hydroponic farms that are self contained and then we actually run a lot of the day to day maintenance remotely so that's nutrients, PH, irrigation, lighting, all of the kind of day to day variables you need to control for optimal plant growth.""I would say just in terms of executing on our plans, that focus is everything. I think when we look at again, compared to the status quo, we have elevated the concept, it's easy to use, but we've also implemented a lot of features for food safety traceability and scaling and tracking the efficacy of the farms that we know how much is growing and who's doing it. These are really...

Since 1988, La Jolla Cosmetic founders Dr. Merrel and Marie Olesen have dedicated their lives to delivering the best possible experiences for cosmetic patients, encouraging staff to also put their hearts into every patient interaction. From sending letters thanking patients for making appointments to personally writing post care instructions for each patient, LJC's founders created an environment that empowers cosmetic patients and delivers individualized care.Hear how their dedication to helping patients feel safe and comfortable extended far beyond the practice, from their experience writing the book Cosmetic Surgery for Dummies to their visionary patient care, communication, and feedback systems being adopted to help patients all over the world.Read more about the story of LJCRead more about LJC President Marie OlesenLa Jolla Cosmetic is located just off the I-5 San Diego Freeway at 9850 Genesee Ave, Suite 130 in the Ximed building on the Scripps Memorial Hospital campus. Our Carlsbad medical spa is located at 7730 El Camino Real Suite C at The Beacon La Costa.To learn more, go to ljcsc.com or follow the team on InstagramThe La Jolla Cosmetic Podcast is a production of The Axis

Alexander Olesen is the CEO & Co-Founder of Babylon Micro-Farms Inc. He's a social entrepreneur, keynote and TEDx speaker, and urban agriculture expert. Today we talk about how he's been building a successful business making produce much more sustainable than conventional methods. We get into the ups and downs of social entrepreneurship, and especially why this is such a timely concept for us all getting access to better food.     ➡️https://www.linkedin.com/in/alexander-olesen-7aa4a16a/ ➡️https://babylonmicrofarms.com/ ➡️ Highlights: https://rosspalmer.com/alexander-olesen

Hey there, friends! In this episode, Sannah and Amanda magically *aligned* with a common story theme of the unexplained. First, Sannah tells the INSANE story of Evatima Tardo, a real medical anomaly, whom Harry Houdini himself admired. Then in Amanda's tale, she explores the mysterious and… shocking… phenomenon surrounding the Olesen family of Elgin, Illinois. Buckle up! This one is crazy!   Do you have a personal #SHOOKstory you would like us to share on a future episode?    Submit your spooky story here: https://www.shookpodcast.com/shareyourstory.html   Alternatively, you can send an email to shookparanormalpod@gmail.com Let's be friends! All our main links: https://linktr.ee/shookpodcast    Exclusive content: https://www.patreon.com/shookpodcast    Instagram: https://www.instagram.com/shookpodcast/    YouTube: https://www.youtube.com/channel/UCG5XKSY_rzrBDOeMhz7guhA    TikTok: https://www.tiktok.com/@shookpodcast    Reddit: https://www.reddit.com/r/Shookpodcast/    Every Season is Spooky Season… https://www.facebook.com/groups/1115739589042652    Facebook: https://www.facebook.com/shookparanormalpod This episode was made possible by Riverside   Sources:    The Extraordinary Body of Evatima Tardo by Bess Lovejoy   The Witch of Lime Street: Séance, Seduction, and Houdini in the Spirit World by David Jaher   Unsolved Mysteries, S9, E13   Unsolved Mysteries Wiki, Olesen Family

In this episode the guys chat about the use of creatine in conjunction with BFR resistance training. As usual they breakdown our current knowledge with an emphasis on safety and then get into the meat and potatoes of what has been shown in the BFR literature. Here are the papers mentioned: Rawson, E. S., Clarkson, P. M., & Tarnopolsky, M. A. (2017). Perspectives on Exertional Rhabdomyolysis. Sports Medicine , 47(Suppl 1), 33–49. Harmon, K. K., Stout, J. R., Fukuda, D. H., Pabian, P. S., Rawson, E. S., & Stock, M. S. (2021). The Application of Creatine Supplementation in Medical Rehabilitation. Nutrients, 13(6). https://doi.org/10.3390/nu13061825 Olsen, S., Aagaard, P., Kadi, F., Verney, G. T., Olesen, J. L., Suetta, C., & and Kjær, M. (2006). Creatine supplementation augments the increase in satellite cell and myonuclei number in human skeletal muscle induced by strength training. The Journal of Physiology, 573, 525–534. Hespel, P., Op't Eijnde, B., Van Leemputte, M., Ursø, B., Greenhaff, P. L., Labarque, V., Dymarkowski, S., Van Hecke, P., & Richter, E. A. (2001). Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans. The Journal of Physiology, 536(Pt 2), 625–633. Hultman, E., Söderlund, K., Timmons, J. A., Cederblad, G., & Greenhaff, P. L. (1996). Muscle creatine loading in men. Journal of Applied Physiology, 81(1), 232–237. Suga, T., Okita, K., Takada, S., Omokawa, M., Kadoguchi, T., Yokota, T., Hirabayashi, K., Takahashi, M., Morita, N., Horiuchi, M., Kinugawa, S., & Tsutsui, H. (2012). Effect of multiple set on intramuscular metabolic stress during low-intensity resistance exercise with blood flow restriction. European Journal of Applied Physiology, 112(11), 3915–3920. Ingemann-Hansen, T., Halkja~r-Kristensen, J., & Halskov, O. (1981). Skeletal Muscle Phosphagen and Lactate Concentrations in lschaemic Dynamic Exercise. European Journal of Applied Physiology, 46, 261–270. Sousa-Silva, R. C., Holewa, J. M., de Araújo Pessôa, K., Zhi Xia, Z., Lauver, J. D., Rossi, F. E., & Zanchi, N. E. (2/2023). Creatine supplementation combined with blood flow restriction training enhances muscle thickness and performance- a randomized, placebo-controlled, and double-blind study.pdf. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition et Metabolisme. https://doi.org/10.1139/apnm-2022-0209 Intro sound clip: Trick or Treat (instrumental) by RYYZN https://soundcloud.com/ryyzn Creative Commons — Attribution 3.0 Unported — CC BY 3.0 Free Download / Stream: https://bit.ly/l_trick-or-treat Music promoted by Audio Library https://youtu.be/uNPXJ9CDzbc

Highlights from the conversation:What does AVRL do in the space? (0:15)AVRL's unique approach to delivering white glove service to companies (1:17)What does growth look like in AVRL's hand-selection of clients? (5:44)The niche approach to gaining quality of customers, not quantity (6:46)Laser focus on delivering results, not promises (8:45)Combating a recession with growth (11:55)Being a voice for the industry on LinkedIn (15:12)Content Is for Closers is a bi-weekly podcast powered by HEARD Media. Each episode we get into the nitty-gritty details with an entrepreneur, marketer, or business owner about how they literally use content to close more business, drive more sales, and grow their company.HEARD helps service-based businesses leverage digital content to close sales. Learn more about HEARD by visiting trustheard.com.* Want to be featured in a future episode? Drop your question/comment/criticism/love here: https://podcasts.apple.com/us/podcast/content-is-for-closers/id1280589855* Support the pod by spreading the word. Use this link to share: www.contentisforclosers.com

Chadd Olesen and Joe Lynch discuss the tech that automated 60 million shipments. That tech belongs to AVRL and Chadd is the Co-Founder and CEO. AVRL's Generation platform converts complex domain expertise into a rich, storied decision trees that can be cross-linked, aggregated across domains, and parsed by existing ERP, smart forms, mobile apps, and RPA. About Chadd Olesen  Chadd Olesen is the Co-Founder and CEO of AVRL, an Austin-based automation company providing the supply chain and logistics architecture required to connect intricate systems and automate complex problems. Chadd and Co-Founder Nikolai Pereira started AVRL in 2017 and the company has grown so quickly that it is recognized as one of the fastest growing companies in America by Inc. magazine. About AVRL AVRL Generation is the world's most sophisticated platform for applying decision-making technology, while being manageable by your non-technical workforce. This platform uses decision trees in a way never seen before. With our proprietary technology, Generation allows users to convert their complex domain expertise into a rich, storied decision trees that can be cross-linked and aggregated across domains, allowing our users to reach their customers through rich APIs, sophisticated chatbots, automated content serving mechanisms and robotic process management. Key Takeaways: The Tech that Automated 60 Million Shipments  Chadd Olesen is the Co-Founder and CEO of AVRL, an Austin-based automation company providing the supply chain and logistics architecture required to connect intricate systems and automate complex problems. AVRL works with more than half of the top 100 3PLs, which is how they have been able to automate over 60 million shipments. 3PLs, carriers, and shippers come to AVRL to connect disparate systems (TMS, WMS, ERP, etc.) and automate processes. “Over the course of every year, we identify 18 companies to work with us to automate their processes.” Copied from AVRL's website. Learn More About The Tech that Automated 60 Million Shipments  Chadd on LinkedIn AVR on LinkedIn Contact AVR The Logistics of Logistics Podcast If you enjoy the podcast, please leave a positive review, subscribe, and share it with your friends and colleagues. The Logistics of Logistics Podcast: Google, Apple, Castbox, Spotify, Stitcher, PlayerFM, Tunein, Podbean, Owltail, Libsyn, Overcast Check out The Logistics of Logistics on Youtube  

"We're helping people who've never grown crops before be successful farmers in places that they never thought they could.” —Alexander Olesen   Simplifying farming to provide more access to good food is becoming the new norm. With technology advancing the way it has, people are now able to grow their own food in spaces where they never thought were possible with fewer resources needed than traditional farming methods.    This was the idea behind Babylon Micro-Farms. It all began when co-founders Alexander Olesen and Graham Smith started working on automating most of the processes associated with indoor farming. Eventually, they came up with the idea to design a low-cost Micro-Farm™ by taking advantage of sustainable hydroponic farming and all its benefits. Their technology not only simplified crop production but made it more executable for everyone as well.    In this episode, Justine interviews Alexander about how this revolutionary technology is making an impact on agriculture, climate, and people's lives. Alexander also shares helpful business advice on keeping the momentum going, raising funds, the importance of having mentors, and how co-founders can work together to keep their businesses growing and thriving despite their differences.  Meet Alexander: Alexander Olesen is the CEO & Co-Founder of Babylon Micro Farms Inc., a company dedicated to bringing urban farming solutions to cities all over the world. He has become a well-respected Social Entrepreneur, presented at numerous keynotes and TEDx speaker events, and has become a respected Urban Agriculture Expert. He is passionate about building a more sustainable food system and is determined to make urban farming a reality for everyone through their Micro-Farms.   Website Facebook Twitter Instagram LinkedIn Connect with NextGen Purpose: Website Facebook Instagram  LinkedIn YouTube Episode Highlights: 01:21 What Are Micro-Farms?   05:44 Different Skillset, Same Passion 08:09 Business Advice 13:18 How Great Co-Founders Make It Work   

We do it every day. We search on the internet for some information. Many ask, why is that easy? And yet doing the same thing at my company is hard sometimes, not even possible. And when you do get the data, it's unclear where it's from or the degree you can trust it or use The post The Enterprise Data Catalog with Ole Olesen-Bagneux appeared first on Software Engineering Daily.

Today, we recap the Warriors' finals win (2:50) with some potential takeaways for founders (14:00). Next, Jason speaks with Jesse Powell: founder, and CEO of crypto exchange Kraken, and they discuss the state of crypto and the recent hit piece the NYT published on him (48:06). For this week's OK Boomer segment, Producer Rachel sits down with Alexander Olesen, co-founder, and CEO of Babylon Micro-Farms (2:07:41). (0:00) Jason and Molly tee up today's show! (2:50) Warriors win! Recapping the Warriors' finals run (12:47) ActiveCampaign - Get 10% off your ActiveCampaign subscription today at https://activecampaign.com/promo/twist (14:00) Downmarket: what can you do? Lessons founders can learn from the Warriors' leadership (22:37) Lemon.io - Get 15% off your first 4 weeks of developer time at https://Lemon.io/twist (23:55) Work harder, work smarter (30:25) Microsoft for Startups Hub - Apply in 5 minutes, no funding required, sign up at http://aka.ms/thisweekinstartups (31:41) Toss to Jason's interview with Jesse Powell, founder, and CEO of Kraken (48:06) Jesse Powell speaks with Jason about his NYT hit piece, crypto, and company culture (2:02:04) Recapping Jesse Powell + Toss to OK Boomer with Alexander Olesen, CEO, and Co-Founder of Babylon Micro-Farms (2:07:41) OKB: Producer Rachel speaks with Alexander Olesen (2:26:00) Outro